Congenital heart disease

There are 64 papers on congenital heart disease in aging research: 1 trial and 43 observational studies in people, 3 in animals, 14 reviews. The newest story, Oct 26, 2026: “Mental disorders tied to lower survival in congenital heart disease”.

Disease

64 papers study it36 more mention it35 findings

26 new papers in 30 daysSee all 100 papers on congenital heart disease

“However, the IR of fractures for all patients with CHD was slightly higher than that of controls (7.42 vs. 7.06 per 10,000 person-years).”
Fractures in patients with and without congenital heart disease - A nationwide register-based cohort studyInternational journal of cardiology. Congenital heart disease2022doi:10.1016/j.ijcchd.2022.100413
  • Human trial1
  • Humans43
  • Animals3
  • In silico1

Effects

12

Telomere length

no changein humans1downin humans1OR 1.5

1 study
  1. Congenital heart disease was not clearly linked with telomere length in humans (simple CHD vs healthy peers) (OR 1.5 (95% CI 0.9-2.6), p=0.130).

    “not in patients with simple CHD (OR 1.5 (95% CI 0.9-2.6), p=0.130)”

    Humanssimple CHD vs healthy peersblood

    Telomere length in patients with adult congenital heart disease

    ESC Congress 2026 abstract

  2. Congenital heart disease is linked with lower telomere length in humans (adults with CHD vs healthy controls) (0.95±0.20 vs 0.99±0.19, p<0.001).

    “Adults with CHD had shorter relative TL compared to healthy controls (0.95±0.20 vs 0.99±0.19 respectively, p<0.001)”

    Humansadults with CHD vs healthy controlsblood

    Telomere length in patients with adult congenital heart disease

    ESC Congress 2026 abstract

More on Telomere length

Age of onset of comorbidities

downin humans1

1 study
  1. Congenital heart disease is linked with lower age of onset of comorbidities in humans (severe CHD) (2 to 3 decades earlier).

    “Median ages of onset for most comorbidities occurred below age 40 in severe CHD, 2 to 3 decades earlier than patients with nonsevere CHD”

    Humanssevere CHD

    Severe congenital heart disease links to earlier multimorbidity

    Journal of the American Heart Association

DunedinPACE

upin humans1

1 study
  1. Congenital heart disease is linked with higher DunedinPACE in humans (moderate and complex congenital heart disease) (P = .008 and P = .016).

    “and a higher pace of ageing (P = .008 and P = .016, respectively)”

    Humansmoderate and complex congenital heart disease

    Accelerated epigenetic ageing in congenital heart disease: the AccelerAGE study

    European heart journal

More on DunedinPACE

GrimAge2

upin humans1

1 study
  1. Congenital heart disease is linked with higher GrimAge2 in humans (moderate congenital heart disease) (+2.1 years, P = .045).

    “GrimAge2 (+2.1 years, P = .045; +2.3 years, P = .022)”

    Humansmoderate congenital heart disease

    Accelerated epigenetic ageing in congenital heart disease: the AccelerAGE study

    European heart journal

More on GrimAge2

PhenoAge

upin humans1

1 study
  1. Congenital heart disease is linked with higher PhenoAge in humans (moderate congenital heart disease) (+3.0 years, P = .019).

    “patients with moderate and complex congenital heart disease exhibit significant age acceleration with PhenoAge (+3.0 years, P = .019; +5.5 years, P < .001)”

    Humansmoderate congenital heart disease

    Accelerated epigenetic ageing in congenital heart disease: the AccelerAGE study

    European heart journal

More on PhenoAge

Adverse events

no changein humans1

1 study
  1. Congenital heart disease was not clearly linked with adverse events in humans (18 versus 22 events; rate ratio 1.02).

    “There were no differences in number (CHD: 18 vs. no CHD 22 events; rate ratio 1.02, p = 0.94) or severity (p = 0.25)”

    HumansAdults with Down syndrome participating in an exercise intervention; congenital heart disease versus no congenital heart disease12 months

    Outcomes of an Exercise Intervention in Adults With Down Syndrome and Congenital Heart Disease: A Secondary Analysis

    Journal of intellectual disability research : JIDR

Frailty

no changein humans1

1 study
  1. Congenital heart disease was not clearly linked with frailty in humans (36.5% vs 29.0%, P = 0.26).

    “there was no statistical difference in the prevalence of prefrailty/frailty between adults with CHD and controls (36.5% vs 29.0%, P = 0.26).”

    Humans

    Frailty and Cognitive Function After the Age of 40 in Adults With Moderate or Severe Congenital Heart Disease

    CJC pediatric and congenital heart disease

Cognitive function

no changein humans1

1 study
  1. Congenital heart disease was not clearly linked with cognitive function in humans (mean score 27.1 vs 26.9, P = 0.59).

    “Adults with CHD and controls did not differ in terms of mean score on the Montreal Cognitive Assessment (mean score 27.1 vs 26.9, P = 0.59).”

    Humans

    Frailty and Cognitive Function After the Age of 40 in Adults With Moderate or Severe Congenital Heart Disease

    CJC pediatric and congenital heart disease

APOM

downin humans1

1 study
  1. Congenital heart disease is linked with lower APOM in humans (cyanotic congenital heart disease vs controls) (p = 0.04).

    “lower ApoM (p = 0.04), and HDL concentrations (p = 0.02).”

    Humanscyanotic congenital heart disease vs controlsserum

    Can we know more about atherosclerosis in cyanotic patients with congenital heart disease-the potential role of sphingosine-1-phosphate?

    Frontiers in cardiovascular medicine

More on APOM

Sphingosine-1-phosphate

upin humans1

1 study
  1. Congenital heart disease is linked with higher Sphingosine-1-phosphate in humans (cyanotic congenital heart disease vs controls) (p = 0.04).

    “Patients with cyanosis are characterized by higher S1P serum levels (p = 0.04)”

    Humanscyanotic congenital heart disease vs controlsserum

    Can we know more about atherosclerosis in cyanotic patients with congenital heart disease-the potential role of sphingosine-1-phosphate?

    Frontiers in cardiovascular medicine

More on Sphingosine-1-phosphate

All 12

Associations

22

Gestational diabetes mellitus

upin humans1RR 1.81

1 study
  1. Congenital heart disease is associated with gestational diabetes mellitus in humans (RR 1.81, 1.44, 1.34, 1.18, and 1.13 at ages <20, 20–24, 25–29, 30–34, and 35–39, respectively).

    “Across all age groups, women with CHD had higher GDM incidence than the general population”

    HumansPregnancies in women with congenital heart disease compared with the general Quebec populationfemalesn = 13,308

    Incidence and Risk Factors of Gestational Diabetes Mellitus in Women with Congenital Heart Disease

    AHA Scientific Sessions 2026 abstract

More on Gestational diabetes mellitus

Comorbidity burden

upin humans1

1 study
  1. Congenital heart disease is associated with comorbidity burden in humans (Atherosclerotic disease; comparison with matched controls).

    “a disproportionately higher adverse event and comorbidity burden at younger ages despite a favorable conventional risk factor profile.”

    HumansAtherosclerotic disease; comparison with matched controlsn = 35,064

    Heart defects linked to more complications in artery disease

    ESC Congress 2026 abstract

Major adverse clinical events

upin humans1

1 study
  1. Congenital heart disease is associated with major adverse clinical events in humans.

    “especially ACHD with more complex defects suffered a disproportionately higher burden of MACE, especially stroke”

    HumansAtherosclerotic disease; comparison with matched controls, especially in patients with more complex congenital heart defectsn = 35,064

    Heart defects linked to more complications in artery disease

    ESC Congress 2026 abstract

Non-cardiac comorbidity

upin humans1HR 1.25–2.48

1 study
  1. Congenital heart disease is linked with a higher risk of non-cardiac comorbidity in humans (compared to individuals without CHD) (HR 1.25 to 2.48).

    “Hazard ratios (HRs), adjusted for major demographic and lifestyle factors, ranged from 1.25 (skin disease) to 2.48 (blood disease).”

    Humanscompared to individuals without CHD

    Less complex heart defects linked to more non-heart illness

    ESC Congress 2026 abstract

More on Non-cardiac comorbidity

Telomere length

upin humans1OR 2.3

1 study
  1. Congenital heart disease is associated with telomere length in humans (moderate CHD vs healthy peers) (OR 2.3 (95% CI 1.5-3.5), p<0.001).

    “The odds of short TL were higher in patients with moderate CHD (OR 2.3 (95% CI 1.5-3.5), p<0.001)”

    Humansmoderate CHD vs healthy peersblood

    Telomere length in patients with adult congenital heart disease

    ESC Congress 2026 abstract

More on Telomere length

Lithium

upin humans1

1 study
  1. Lithium is associated with congenital heart disease in utero exposure; relative to other mood stabilizers.

    “in utero exposure to lithium was associated with an increased incidence of congenital heart defects, in males but not females.”

    Humansin utero exposure; relative to other mood stabilizersheartmales

    Network-enabled drug repurposing identifies lithium to promote cardiomyocyte proliferation

    bioRxivPreprint

More on Lithium

Comorbidities

upin humans1

1 study
  1. Congenital heart disease is linked with a higher risk of comorbidities in humans (severe versus nonsevere CHD) (≥2-fold higher).

    “By age 40 years, cumulative probabilities for developing cardiac, vascular, endocrine/metabolic, digestive, infectious, renal, and neurological disease were ≥2-fold higher in severe versus nonsevere CHD.”

    Humanssevere versus nonsevere CHD

    Severe congenital heart disease links to earlier multimorbidity

    Journal of the American Heart Association

Retinal fundus imaging

upin humans1+91% auc

1 study
  1. Retinal fundus imaging predicts congenital heart disease in humans (CHD detection) (up to 91% AUC).

    “Convolutional neural networks achieved up to 91% AUC for CHD detection”

    ReviewCHD detection

    Retinal Biomarkers for Cardiovascular Disease Prediction: A Review Focused on CHD AHD Valvular Disorders and Cardiomyopathies

    Current cardiology reviews

More on Retinal fundus imaging

Accelerated biological aging

upin humans1

1 study
  1. Congenital heart disease is associated with accelerated biological aging in humans.

    “The findings support the concept of accelerated aging and emphasize the need for tailored interdisciplinary care strategies.”

    Humansn = 297

    Dual Disease Burden: Growing Older with Congenital Heart Disease and Hereditary Metabolic and Connective Tissue Disorders-Data from the PATHFINDER-CHD Registry on Heart Failure

    Geriatrics (Basel, Switzerland)

High comorbidity burden

upin humans1

1 study
  1. Congenital heart disease is associated with high comorbidity burden in humans.

    “Older patients with CHD represent a clinically complex cohort with high comorbidity burden.”

    Humansn = 297

    Dual Disease Burden: Growing Older with Congenital Heart Disease and Hereditary Metabolic and Connective Tissue Disorders-Data from the PATHFINDER-CHD Registry on Heart Failure

    Geriatrics (Basel, Switzerland)

All 22

Trial sponsors

Funding

9 grants since 2016

National Heart, Lung, and Blood Institute$837KAmerican Heart Association$208KJapan Society for the Promotion of Science¥2.9M

Latest

Dec 2025: 0Jan 2026: 6Feb 2026: 3Mar 2026: 3Apr 2026: 0May 2026: 1Jun 2026: 2Jul 2026: 0Aug 2026: 0Sep 2026: 7Oct 2026: 16Nov 2026: 1250 papers in 12 months
The American Journal of Cardiology

Artificial intelligence better flags structural heart disease

The model’s score for distinguishing disease from no disease was 0.80, versus 0.75 for prediction using clinical information and standard heart-tracing findings.The model’s score for distinguishing disease from no disease was 0.80, versus 0.75 for prediction using clinical information and standard heart-tracing findings.

Cross-sectional · 3,779 peopleStructural heart disease
ESC Congress 2026 Abstract

Mental disorders tied to lower survival in congenital heart disease

At 50 years of follow-up, survival probability was 55% for patients with a mental disorder compared with 74% for matched patients without one.At 50 years of follow-up, survival probability was 55% for patients with a mental disorder compared with 74% for matched patients without one.

Cohort · 18,749 peopleCongenital heart disease
ESC Congress 2026 Abstract

Heart defects linked to more complications in artery disease

An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.

Cohort · 35,064 peoplePopulations

See all 100 papers on congenital heart disease